Arsham Sheybani

Medicine & Life Sciences

1. Glaucoma 100%
2. Open Angle Glaucoma 41%
3. Intraocular Pressure 41%
4. Stents 34%
5. Gels 33%
6. Cataract 30%
7. Eye 30%
8. Macular Degeneration 21%
9. Exfoliation Syndrome 19%
10. Aqueous Humor 18%
11. Growth Differentiation Factor 15 17%
12. Phacoemulsification 16%
13. Cost of Illness 15%
14. Bevacizumab 15%
15. Glaucoma Drainage Implants 14%
16. Trabeculectomy 13%
17. AR-13324 13%
18. Intraocular Lenses 12%
19. Ocular Vision 12%
20. Visual Acuity 11%
21. Choroidal Neovascularization 11%
22. Paecilomyces 11%
23. Equipment and Supplies 11%
24. Thiazoles 10%
25. Visual Fields 10%
26. Fibromuscular Dysplasia 9%
27. Vascular Endothelial Growth Factor A 9%
28. Blister 9%
29. Penicillium 9%
30. Epiretinal Membrane 9%
31. Corneal Edema 9%
32. Histoplasmosis 8%
33. Ranibizumab 8%
34. Electroretinography 8%
35. Penetrating Keratoplasty 8%
36. Intraocular Lens Implantation 8%
37. Therapeutics 8%
38. Oxides 8%
39. Keratitis 7%
40. Retinal Vessels 7%
41. Filtering Surgery 7%
42. Hydrodynamics 7%
43. Uveitis 7%
44. Safety 7%
45. Oligonucleotides 7%
46. Eye Diseases 6%
47. Reoperation 6%
48. Anterior Chamber 6%
49. Fistula 6%
50. Gelatin 6%